Related Experiment Video
Updated: Apr 15, 2026
08:43
A Fluorescence-based Lymphocyte Assay Suitable for High-throughput Screening of Small Molecules
Published on: March 10, 2017
11.1K
Flow Cytometry: Impact on Early Drug Discovery
Bruce S Edwards1, Larry A Sklar2
1Center for Molecular Discovery, Innovation Discovery and Training Center, Health Sciences Center, University of New Mexico, Albuquerque, NM, USA bedwards@salud.unm.edu.
Journal of Biomolecular Screening
|March 26, 2015
Summary
HyperCyt sampling technology enhances flow cytometry for high-throughput drug discovery screening. This innovation enables rapid analysis of thousands of compounds daily, reducing costs and accelerating lead candidate profiling.
Area of Science:
- Biotechnology
- Pharmacology
- Cell Biology
Background:
- Flow cytometry offers multi-parameter cell analysis at high speeds.
- Traditional "sip-and-spit" methods limit flow cytometry's throughput in drug discovery.
- Existing technologies restrict comprehensive analysis early in the drug discovery pipeline.
Purpose of the Study:
- To introduce and evaluate the impact of HyperCyt sampling technology on drug discovery screening.
- To demonstrate the potential of advanced flow cytometry for high-throughput primary screening.
- To highlight how new technologies enable early profiling of lead candidates.
Main Methods:
- Utilizing HyperCyt sampling technology for high-throughput analysis.
- Implementing target-multiplexing and extended multiparameter analyses.
- Employing advanced compound library formatting strategies.
Main Results:
- HyperCyt enables primary screening of tens of thousands of compounds per day.
- Reduced sample volumes minimize reagent costs and compound usage.
- Successful screening of numerous targets in various well formats.
Conclusions:
- HyperCyt sampling technology significantly advances flow cytometry for drug discovery.
- This technology facilitates early-stage lead candidate profiling and reduces experimental costs.
- Future advancements in flow-based imaging and mass spectrometry will further enhance single-cell profiling for drug discovery.
